The Associated Press The NFL is requiring coaches, front-office staff and team personnel to receive a COVID-19 booster by Dec. 27. In a memo sent to teams on Monday and obtained by The Associated Press, the league said: “Given the increased prevalence of the virus in our communities, our experts have recommended that we implement […]
Search Results for: NEW
13
Dec
Dec
This December, BioReference is proud to be celebrating an exciting milestone – our 40th anniversary. For over four decades, our dedicated team has worked to build a legacy of scientific expertise through innovative and tailored laboratory test solutions. Join us in celebrating our 40th anniversary and learn more about our dynamic evolution. BioReference Celebrates 40 […]
08
Dec
Dec
MIAMI, Dec. 08, 2021 (GLOBE NEWSWIRE) — OPKO Health, Inc. (NASDAQ: OPK) today announced that the U.S. Food and Drug Administration (FDA) has approved OPKO’s 4Kscore Test. This test is approved for use in men age 45 and older who have not had a prior prostate biopsy or are biopsy negative and have an age-specific abnormal total PSA and/or […]
02
Dec
Dec
As you may have seen in the news, a new variant of SARS-CoV-2, B.1.1.529, has been classified by the World Health Organization (WHO).1 Named “Omicron,” this variant of concern was first reported in South Africa on November 24, 2021.1 With the first case of this variant in the United States confirmed on December 1, 2021,2 […]
Press Release
BioReference Laboratories Announces Readiness for COVID-19 Testing if the Omicron COVID-19 Variant Emerges in The U.S.
29
Nov
Nov
ELMWOOD PARK, N.J., November 29, 2021 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), announced COVID-19 testing preparedness for the Omicron Variant. BioReference’s PCR diagnostic tests for SARS-CoV-2 COVID-19 are based on recognizing specific RNA target genes that are common to all coronaviruses. To date, the diagnostic targets have not changed with the novel […]
29
Nov
Nov
According to the Centers for Disease Control and Prevention (CDC), outdoor activities are still safer to take part in than indoor activities due to COVID-19.1 Though, with chilly weather settling in in many regions, this may mean changing some of our go-to adventures. Luckily, fall and winter bring a host of new opportunities to enjoy […]
23
Nov
Nov
Thanksgiving brings the beginning of the winter holiday season – a time for connection and celebration. As family gathers around the table to give thanks, a toast to health is often in order. This year, take the opportunity to touch base with your loved ones about important familial health matters like cancer screening for hereditary […]
21
Oct
Oct
Exciting news for Android users. We previously shared that Apple users can access test results through Apple Health. Now, Android users can do the same through the CommonHealth mobile application. BioReference Laboratories now supports access to test results through CommonHealth on Android devices. This new offering makes it easy to centralize your health records from […]
PM360 Hillary M. Titus, Director of External Communications, BioReference Laboratories, Inc. As the world’s leading diagnostics labs raced to develop effective COVID-19 testing programs, BioReference Laboratories’ existing proprietary technology was already far ahead of the competition. However, the small lab was virtually unknown. In order to launch new testing services, BioReference had to become part […]
18
Oct
Oct
In honor of Breast Cancer Awareness Month, Terri offers her perspective on her breast cancer treatment, the positive attitude and silver-lining she discovered through her journey.
